Travel + Leisure Co. to Present at the Morgan Stanley 3rd Annual Travel & Leisure Conference
ORLANDO, Fla.--(BUSINESS WIRE)-- Travel + Leisure Co. (NYSE:TNL) announced today that Michael D. Brown, President and CEO, and Erik Hoag, CFO, will participate in a fireside chat session at the Morgan Stanley 3rd Annual Travel & Leisure Conference on Tuesday, June 3, 2025 at 8:00 a.m. EDT.
A live audio webcast will be available in the investor relations section of the company's website at travelandleisureco.com/investors. A replay will be available approximately 24 hours after the ending of this event.
About Travel + Leisure Co.
Travel + Leisure Co. (NYSE:TNL) is a leading leisure travel company, providing more than six million vacations to travelers around the world every year. The company operates a portfolio of vacation ownership, travel club, and lifestyle travel brands designed to meet the needs of the modern leisure traveler, whether they're traversing the globe or staying a little closer to home. With hospitality and responsible tourism at its heart, the company's nearly 19,000 dedicated associates around the globe help the company achieve its mission to put the world on vacation. Learn more at travelandleisureco.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
From Samsonite to Away, These Luggage Deals Make It Easy to Replace Your Tired Gear for the Start of Travel Season
If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. With the start of the summer travel season officially kicking off, you might be pulling your old suitcases out of storage only to realize the zipper is broken, or that the budget hard shell suitcase you bought is just not durable enough. The good news is that even past Memorial Day, you can still find plenty of summer sales of up to up to 80% off travel essentials from the best luggage brands around, on everything from our editor-beloved carry-ons, to TSA-friendly travel backpacks. Even some of our favorite accessories to make it through layovers and long-haul flights are still discounted right now. More from Rolling Stone Cory Booker Is Turning His Record-Setting Senate Speech Into a Book F1 Star Charles Leclerc's New Headphones Collab Sold Out In Minutes - Here's How to Get An Almost Identical Pair Adults Are Using These Coloring Books to Help Reduce Anxiety - Here's Where to Buy Them Online for Under $7 Save up to 60% on brands like Bagsmart, Luggex, Nine West and more Up to 20% off on luggage, travel bags, and accessories BOGO 10% off and buy two, get one 15% off Up to 15% off luggage sets Up to 60% off luggage, laptop bags, and duffels Get up to 25% off their most popular luggage kits To make things easier for you as you get ready to board your flight, we've rounded up all the best luggage deals available right now from brands like Away, Calpak, Monos, Tumi, Samsonite, Amazon, American Tourister, and more, with options for carry-on and checked suitcases. We're spotting the best luggage deals are on some of our favorite trusted brands like Samsonite and American Tourister. If you look hard enough you can even find popular celeb and star-loved luggage on sale, like Dagne Dover. We've rounded up a range of deals from a vareity of our favorite brands right below (including luggage sets) so you can pick one that best suits your needs. (Note: luggage sale prices were accurate as of this writing). shop now on away Away luggage is rarely ever on sale, which is why this luggage deal is worth your money. Get our favorite carry-on bags and more for up to 20% off right now. shop now on amazon For carry-on luggage that will fit comfortably under your airline seat (with some extra bells and whistles), Amazon is the place to save up up to 60% on luggage and travel accessories from Amazon Basics, Bagsmart, Luggex, Nine West and more. Who knew Wrangler made more than just hard-wearing jeans, either? This Astral Hardside Carry-On has a built-in 3-in-1 cup holder, phone holder, and a USB port for charging in the back. shop now on american tourister For their 'long weekend savings' event beyond the long weekend, get up to 40% off sitewide on American Tourister. You can also use the promo code SUMMER15 at checkout to receive an extra 15% off (code will stack with current pricing). shop now on antler From feature-packed checked bags for longer trips, to carry-ons, backpacks and day bags, get up to 60% off at Antler. $79.99 $99.99 20% off Buy Now on amazon shop now on bagsmart You can get BOGO 10% off and buy two, get one 15% off luggage on Bagsmart's site, but as a bonus, you can save up to 36% on Bagsmart's carry-on luggage when you shop their sale on Amazon. shop now on baggallini Get 50% off all sale styles, including personal item bags, crossbody and sling bags, packable totes and backpacks. shop now on béis Enjoy 15% off when you combine any roller, weekender and dopp kit from Béis, along with other luggage set deals. shop now on calpak Get up to 60% off luggage, bags, backpacks and more at Calpak right now, including an extra 10% off their bestselling Luka Duffel for a super limited (36-hour) time. shop now on dagne dover Get 25% off Dagne Dover's popular pre-curated luggage kits, where you can mix and match a variety of luggage, bags, duffels, backpacks and packing cubes. shop now on delsey Paris Save up to 40% off sitewide on Delsey Paris' elegant carry-ons and spacious checked bags, and get an extra 10% off with promo code EXTRA10. Right now, you can also score a free set of packing cubes with a purchase from Millie Bobby Brown's collab collection florence by mills x Delsey Paris. shop Now on herschel Take up to 40% off select Herschel luggage, backpacks, duffle bags, lunch boxes and more travel accessories (think rain jackets and UV protective bucket hats). shop now on lo & sons Get up to 40% off select styles of travel bags, totes, duffles, and more — Lo & Sons says on their site that with tariff increases in the horizon, they won't be able to offer these deals for long. shop now on mark & graham Take up to 60% off select personalized bags, luggage and more from Mark & Graham, plus an extra 20% off clearance items and free shipping on orders over $150 with promo code SHIPFREE. shop now on monos Simplify your travel experience by saving up to $150 when you bundle Monos' curated luggage and travel bag sets. shop now on nex From now through May 31, enjoy up to 65% off Nex's limited-edition 'Hawaii 2024: Return With More Than Memories' luggage collection for AAPI Month before it's discontinued. You can also save 15% on all orders over $250 and up to 20% off luggage bundles. shop now on roam The customizable luggage brand is letting you save more the more you spend — get 20% off when you spend $599 or more, 25% off on $500 or more or 30% off orders of $1,200 and up. shop Now on roverlund Traveling with your furry best friend? Save up to 20% on Roverlund's pet carrier and luggage bundles. shop now on samsonite If you're unsure whether you need to stock up on carry-ons for a short trip or large checked luggage for your weeklong trek, you'll want to take advantage of this Samsonite sale — for their Summer Kickoff Event, save up to 40% sitewide, no promo code needed. shop Now on solgaard Take up to $106 off Solgaard's award-winning luggage with built-in closet systems — that means all-time low prices starting at $229. shop now on solo new york Save up to 50% on Solo New York's sustainable bags and luggage that repurpose discarded plastic bottles for material. shop now on tumi Get up to 40% off luggage, backpacks, bags and more during Tumi's Semi-Annual Sale (with new styles recently added). Best of Rolling Stone The Best Audiophile Turntables for Your Home Audio System
Business Wire
an hour ago
- Business Wire
Avistone Announces Encouraging Results for Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression at ASCO Annual Meeting 2025
BEIJING--(BUSINESS WIRE)--Beijing Avistone Biotechnology Co., Ltd ('Avistone'), an innovative biotechnology company focused on precision oncology therapeutics, today announced that the clinical data for Vebreltinib plus Andamertinib (PLB1004), its innovative combination of potent mesenchymal-epithelial transition factor (MET) inhibitor and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), has been presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025. The details of the poster presentation are provided below: Poster title: Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression after failure on EGFR-TKIs treatment: phase Ib/II KYLIN-1 study Abstract Number For Publication: 8632 Session: Poster Session-Lung Cancer- Non-Small Cell Metastatic Location: Poster Board, 112 Session Date/Time: 5/31/2025 1:30pm-4:30pm CDT MET amplification or overexpression is the most common 'off-target' mechanism that drives resistance to EGFR-TKIs in NSCLC patients. The results from Phase Ib/II KYLIN-1 study (NCT06343064) showed that Vebreltinib plus Andamertinib demonstrated notable efficacy and manageable safety in EGFR-mutated NSCLC patients with MET amplification or overexpression after EGFR-TKIs failure. Among the 56 patients enrolled at a dose of Vebreltinib 150mg BID plus Andamertinib 80mg QD (RP2D), the confirmed overall response rate (ORR) was 50.0%, and the median progression-free survival (mPFS) was 9.9 months. In 19 patients with brain metastases, ORR was 42.1% and mPFS was 9.5 months. Grade 3 or higher treatment related adverse events (TRAEs) occurred in 19.6% of the patients. None discontinued treatment or died due to TRAEs. No new safety signal was observed. A multicenter Phase III study, KYLIN-3 study (NCT06970782), is currently ongoing to further evaluate Vebreltinib plus Andamertinib versus platinum-based doublet chemotherapy in patients with EGFR mutations, MET amplification and/or overexpression, locally advanced or metastatic NSCLC following EGFR-TKI failure. To obtain a copy of the poster, please email Avistone. About Vebreltinib Vebreltinib is an orally, potent and selective c-Met inhibitor. Chinese National Medical Products Administration (NMPA) has formally approved the use of Vebreltinib in locally advanced or metastatic NSCLC patients with MET exon 14 skipping mutations, as well as adult patients with isocitrate dehydrogenase mutant astrocytoma with the PTPRZ1-MET fusion gene or glioblastoma with a history of low-grade disease who have the PTPRZ1-MET fusion gene and have failed previous treatments. Currently, Chinese Center for Drug Evaluation (CDE) has formally accepted its New Drug Application (NDA) and granted it priority review, intended for patients with locally advanced or metastatic NSCLC with MET amplification. About Andamertinib (PLB1004) Andamertinib (PLB1004) is an oral, potent, irreversible, and selective EGFR-TKI with potent blood-brain barrier penetration and broad tyrosine kinase activity. Preclinical studies have shown that it can effectively and irreversibly target exon 20 insertion. Additionally, it can also potently target classical EGFR mutations, such as Del19, L858R and T790M with a high degree of selectivity. About Avistone Biotechnology Beijing Avistone Biotechnology Co., Ltd. ('Avistone') is an innovative biotechnology company dedicated to precision therapies with significant unmet medical needs for patients worldwide. Avistone maintains an extensive pipeline of targeted therapies in Non-Small Cell Lung Cancer (NSCLC) and other solid tumors.
Yahoo
2 hours ago
- Yahoo
Eversource Energy (NYSE:ES) Launches US$1.2 Billion Follow-on Equity Offering
Eversource Energy recently filed a $1.2 billion follow-on equity offering, reflecting its strategy to bolster its financial position through capital raising. Over the past month, the company's shares increased by 9%, aligning with the broader market trend, which also saw an upward momentum, rising 1.7% over the last week. Eversource's dividend affirmation and steady earnings announcements complement its robust performance. These financial maneuvers likely added weight to the company's share price movement, reinforcing investor confidence alongside broader market strength, where annual earnings are expected to grow by 14%. Be aware that Eversource Energy is showing 3 risks in our investment analysis and 2 of those can't be ignored. Rare earth metals are the new gold rush. Find out which 24 stocks are leading the charge. The recent $1.2 billion equity offering by Eversource Energy strengthens its financial position, potentially enabling further investments in Massachusetts' transmission and distribution infrastructure. Although the company's shares increased by 9% in the past month, the long-term return over the last year, including both share price appreciation and dividends, was 14.73%. This is noteworthy, given that Eversource underperformed the US Electric Utilities industry, which returned 12.8% over a 1-year period, highlighting a stronger performance in a shorter timeframe. Looking ahead, this capital infusion may positively impact revenue and earnings forecasts, aligning with the anticipated 4.0% revenue growth and increased profit margins over the next three years. The follow-on equity offering could alleviate some pressure from regulatory uncertainties, inflationary pressures, and supply chain challenges, potentially aiding operational efficiency and future earnings stability. Analysts suggest a fair value price target of US$69.27 for Eversource, which is higher than the current share price of US$59.21, indicating a potential upside if their growth assumptions hold true. However, the market remains divided, with price targets ranging from US$47 to US$85. Investors should consider these various factors and assumptions when evaluating the company's long-term value. Gain insights into Eversource Energy's past trends and performance with our report on the company's historical track record. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:ES. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
